Jing Li, Liang Huang, Caifeng Liu, Jianjun Yan, Feng Xu, Mengchao Wu, Yiqun Yan
Department of Hepatic Surgery I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Hepatol Res. 2016 Jul;46(8):727-33. doi: 10.1111/hepr.12610. Epub 2016 Feb 25.
Surgical indications for hepatic hemangiomas are still not clearly defined due to limited data on their natural history. This study aimed to investigate the natural history and growth pattern of hepatic hemangiomas in adults.
From April 2010 to March 2013, adult patients with hepatic hemangioma who had no prior treatment were enrolled. A routine follow up was performed to observe the natural history of the lesions and their tendency to cause complications.
A total of 236 patients were enrolled in the study. The median size of hemangiomas was 4.5 cm (range, 0.6-19.2). During a median follow-up period of 48 months (range, 3-266), 61.0% patients had hemangiomas that increased in size, 23.7% patients had stable lesions and 8.5% patients had hemangiomas that decreased in size. The peak growth period of hemangiomas was in patients of less than 30 years of age (0.46 ± 0.41 cm/year) and the growth rate decreased significantly after 50 years of age (0.21 ± 0.40 cm/year). Hemangiomas of less than 2 cm had the lowest growth rate (0.16 ± 0.42 cm/year). The peak growth rate of hemangioma size was 8-10 cm (0.80 ± 0.62 cm/year), then decreased rapidly to 0.47 ± 0.91 cm/year while the hemangiomas were of more than 10 cm. Only nine patients had severe symptoms caused by hemangioma. No patients presented with hemangioma-related complications.
The majority of hepatic hemangiomas have the tendency to increase in size but rarely cause complications. All the hemangiomas can be safely managed by observation, and surgery is only considered for patients with severe complications.
由于关于肝血管瘤自然病史的数据有限,其手术指征仍未明确界定。本研究旨在调查成人肝血管瘤的自然病史和生长模式。
纳入2010年4月至2013年3月期间未接受过治疗的成年肝血管瘤患者。进行常规随访以观察病变的自然病史及其引发并发症的倾向。
共有236例患者纳入本研究。血管瘤的中位大小为4.5厘米(范围0.6 - 19.2厘米)。在中位随访期48个月(范围3 - 266个月)内,61.0%的患者血管瘤大小增大,23.7%的患者病变稳定,8.5%的患者血管瘤大小减小。血管瘤的生长高峰期出现在30岁以下的患者中(0.46±0.41厘米/年),50岁以后生长速率显著下降(0.21±0.40厘米/年)。小于2厘米的血管瘤生长速率最低(0.16±0.42厘米/年)。血管瘤大小的生长速率峰值出现在8 - 10厘米时(0.80±0.62厘米/年),当血管瘤大于10厘米时迅速降至0.47±0.91厘米/年。仅有9例患者出现由血管瘤引起的严重症状。无患者出现与血管瘤相关的并发症。
大多数肝血管瘤有增大的趋势,但很少引起并发症。所有血管瘤均可通过观察安全处理,仅对出现严重并发症的患者考虑手术治疗。